American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $69,408 | $39,447 | $418,964 | $406,458 |
| - Cash | $62,849 | $28,539 | $26,926 | $27,354 |
| + Debt | $147,367 | $128,325 | $127,127 | $63,694 |
| Enterprise Value | $153,926 | $139,233 | $519,165 | $442,798 |
| Revenue | $1,759,484 | $1,279,185 | $1,149,670 | $943,747 |
| % Growth | 37.5% | 11.3% | 21.8% | – |
| Gross Profit | $117,846 | $82,796 | $95,453 | $77,959 |
| % Margin | 6.7% | 6.5% | 8.3% | 8.3% |
| EBITDA | $1,815 | -$39,351 | $23,089 | $7,853 |
| % Margin | 0.1% | -3.1% | 2% | 0.8% |
| Net Income | -$3,973 | -$5,542 | $2,589 | -$105 |
| % Margin | -0.2% | -0.4% | 0.2% | -0% |
| EPS Diluted | -0.69 | -1.36 | 0.062 | -0.003 |
| % Growth | 49.3% | -2,290% | 2,584% | – |
| Operating Cash Flow | -$4,943 | -$18,118 | -$6,784 | -$26,338 |
| Capital Expenditures | -$20,954 | -$12,283 | -$7,193 | -$8,322 |
| Free Cash Flow | -$25,897 | -$30,401 | -$13,977 | -$34,660 |